ArticleFrontiers in oncology2026
Machine learning model based on dual-layer detector spectral CT radiomics features for differentiating luminal and non-luminal breast cancer.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to explore the value of a machine learning (ML) model based on dual-layer detector spectral CT (DLCT) radiomic features in predicting Luminal versus non-Luminal breast cancer (BC). Methods: A retrospective analysis was conducted on 128 pathologically confirmed BC patients from the Department of Breast Surgery, Jiangsu Cancer Hospital. DLCT chest enhancement images were analyzed, with regions of interest delineated to extract radiomic features. Optimal features were selected through univariate analysis, correlation analysis, and LASSO algorithm, followed by ML model construction. Results: A total of 1,037 radiomic features were extracted, from which 13 optimal features were selected. Combined with clinical parameters (age, body mass index (BMI), and menopausal status), seven ML models were constructed. Among them, the Gaussian Naive Bayes (GNB) model demonstrated the best performance, achieving an area under the receiver operating characteristic curve (AUC) of 0.778 (95% CI: 0.582-0.974), accuracy of 0.821, sensitivity of 0.833, and specificity of 0.778, outperforming the other six models. Conclusions: The GNB model demonstrated relatively superior and stable predictive performance in internal testing, suggesting that DLCT radiomics may offer a potential auxiliary tool for distinguishing between Luminal and non-Luminal BC. However, further validation through large-scale multicenter studies is required.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.